Unsuccessfully treated Hypertension
Using the PRA test to guide addition and subtraction of anti-V and anti-R type drugs
The protocol determines whether PRA is high, medium or low and then adjusts medications accordingly. The protocol assumes that 10% of PRA remains unblocked in patients taking an ACEI or ARB (1).
Low PRA (< 0.65 ng/ml/hr). Anti-V treatment is given until BP is controlled, or until PRA rises into the medium range without BP control at which point the patient is treated as having medium PRA. But, if an uncontrolled patient with low PRA is currently taking an anti-R drug type, the anti-R drug type is first stopped (if no compelling indications) and only restarted if its withdrawal causes BP to rise. BP may actually fall.
Medium or high PRA (> 0.65 ng/ml/hr): Anti-R treatment is given until BP is controlled, or until the PRA level is effectively blocked by an ACEI or ARB (PRA < 6.5 ng/ml/hr) or suppressed to < 0.65 ng/ml/hr at which point the patient is treated as an uncontrolled hypertensive with low PRA (except there is no need to test stopping the anti-R drug).
High PRA (> 4.5 ng/ml/hr). If an uncontrolled patient with high PRA is currently taking an anti-V type drug, the anti-V drug is stopped (if no compelling indication) and only restarted if its withdrawal causes BP to rise. BP may actually fall(2).
|NOT taking an ACEI or ARB||Currently taking an ACEI or ARB|
|Reduce anti-V med||Add anti-V med||Remove anti-R med||Add anti-R med||PRA
|Reduce anti-V med||Add anti-V med||Remove anti-R med||Add anti-R med|
|High > 4.5||Yes||If BP not controlled||High > 45||Yes||If BP not controlled|
|Medium 0.65 – 4.5||Yes||Medium 6.5 – 45||Yes|
|Yes||Yes*||Low 0.65 – 6.5||Yes|
|Low < 0.65||Yes||Yes*|
*Beta adrenergic blockers lower BP by suppressing PRA. If BP rises when the beta blocker is subtracted it should be restored.
Visit by visit description
- Hasler C, Nussberger J, Maillard M, Forclaz A, Brunner HR, Burnier M. Sustained 24-hour blockade of the renin-angiotensin system: a high dose of a long-acting blocker is as effective as a lower dose combined with an angiotensin-converting enzyme inhibitor. Clin Pharmacol Ther. 2005;78(5):501-7.
- Egan BM, Basile JN, Rehman SU, Davis PB, Grob CH, 3rd, Riehle JF, et al. Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial. Am J Hypertens. 2009;22(7):792-801.
- Alderman MH, Cohen HW, Sealey JE, Laragh JH. Pressor responses to antihypertensive drug types. Am J Hypertens. 2010;23(9):1031-7.